Spots Global Cancer Trial Database for Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-)
Official Title: γδ T Cell Immunotherapy for Treatment of Breast Cancer
Study ID: NCT02418481
Conditions
Study Description
Brief Summary: In this study, effects of γδT cells on human breast cancer (her2-, er-,pr-) in combination with tumor reducing surgery, for example cryosurgery going to be investigated.
Detailed Description: Breast tumor will be removed using tumor reducing surgery such as cryosurgery. PBMC of the patient will be separated from peripheral blood. After making them potential cancer killer γδ T Cell and DC-CIK, they will be infused to the patients as immunotherapy.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Biological treatment center in Fuda cancer hospital, Guangzhou, Guangdong, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
